Northwest Biotherapeutics Inc (NASDAQ:NWBO)

8.04
Delayed Data
As of May 22
 -0.08 / -0.99%
Today’s Change
3.79
Today|||52-Week Range
9.45
+50.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-32.8M-67.3M-65.8M-135.6M
 
 
 
 
 
Depreciation10.0K14.0K11.0K11.0K
 
 
 
 
 
Total Other Cash Flow16.0M28.9M13.5M57.0M
 
 
 
 
 
Funds From Operations-16.8M-38.4M-52.3M-78.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.1M-15.6M-14.5M-24.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-14.7M-22.8M-37.8M-54.6M
 
 
 
 
 
 
InvestingCapital Expenditures-49.0K-31.0K---33.7M
 
 
 
 
Fixed Asset Disposal0.000.001.0K--
 
 
Other Investing - Uses0.000.000.00-2.6M
 
 
Net Cash Flow Investing-49.0K-31.0K1.0K-36.4M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings10.0M13.2M-2.3M24.5M
 
 
 
 
 
Long Term Debt Reduction-849.0K-2.2M-2.3M-25.0K
 
 
 
 
 
Net Proceeds Stock Sale5.5M19.2M53.6M63.3M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.001.9M
 
 
Net Cash Flow - Financing14.6M30.1M49.0M85.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash3.0K-40.0K0.000.00
 
 
 
 
Net Change In Cash-132.0K7.4M11.2M-5.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account